Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: Technoloy
No Comments
Drug discovery approaches can be broadly divided into two categories – target-based and phenotypic screening. Historically, medicines were selected for their visible (or perceived) health benefits,…
By Pharmatrax Author
Category: Technoloy
No Comments
Two startups harnessing AI to facilitate drug development — insitro and Exscientia — announced large funding raises this week, nabbing $143 million and $60 million, respectively.…
By Pharmatrax Author
Category: Technoloy
No Comments
Artificial intelligence can make drug discovery and development faster and less risky according to an industry expert, who said understanding complex diseases at the genetic…
By pharmatrax
Category: Technoloy
No Comments
This is what Europe’s biggest corporations got up to this week in innovation. By Maija Palmer CES roundup CES calls itself the “stage for innovation”…
By pharmatrax
Category: Technoloy
No Comments
Research has found that artificial intelligence in drug discovery will be worth $1,434 million by the end of 2024. New research has found that artificial…